Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

This publication has 29 references indexed in Scilit:

• High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
  British Journal of Cancer, 2006
• Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice
  International Journal of Cancer, 2006
• High‐risk human papillomavirus infection of the genital tract of women with a previous history or current high‐grade vulvar intraepithelial neoplasia
  Journal of Medical Virology, 2006
• Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical Trial
  Mayo Clinic Proceedings, 2005
• ANTIGEN-SPECIFIC MEMORY B CELL DEVELOPMENT
  Annual Review of Immunology, 2005
• A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
  Vaccine, 2004
• Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts
  Medical Microbiology and Immunology, 2003
• Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay
  Clinical and Vaccine Immunology, 2003
• Maintenance of B-cell memory by long-lived cells generated from proliferating precursors
  Nature, 1990
• Latent Papillomavirus and Recurring Genital Warts
  New England Journal of Medicine, 1985